Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Consolidated Net Income: 2009-2021

Historic Consolidated Net Income for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to -$85.5 million.

  • Avadel Pharmaceuticals' Consolidated Net Income fell 894.24% to -$23.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$88.2 million, marking a year-over-year decrease of 514.63%. This contributed to the annual value of -$85.5 million for FY2021, which is 1253.58% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Consolidated Net Income stood at -$85.5 million for FY2021, which was down 1,253.58% from -$6.3 million recorded in FY2020.
  • In the past 5 years, Avadel Pharmaceuticals' Consolidated Net Income ranged from a high of $68.3 million in FY2017 and a low of -$95.3 million during FY2018.
  • For the 3-year period, Avadel Pharmaceuticals' Consolidated Net Income averaged around -$56.0 million, with its median value being -$76.0 million (2019).
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Consolidated Net Income soared by 265.40% in 2017, and later tumbled by 1,253.58% in 2021.
  • Avadel Pharmaceuticals' Consolidated Net Income (Yearly) stood at $68.3 million in 2017, then crashed by 239.60% to -$95.3 million in 2018, then rose by 20.22% to -$76.0 million in 2019, then surged by 91.69% to -$6.3 million in 2020, then tumbled by 1,253.58% to -$85.5 million in 2021.